Growth Metrics

Pfizer (PFE) Total Liabilities (2016 - 2026)

Pfizer has reported Total Liabilities over the past 18 years, most recently at $117.2 billion for Q1 2026.

  • Quarterly Total Liabilities changed 0.15% to $117.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $117.2 billion through Mar 2026, changed 0.15% year-over-year, with the annual reading at $121.4 billion for FY2025, 2.81% down from the prior year.
  • Total Liabilities was $117.2 billion for Q1 2026 at Pfizer, down from $121.4 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $137.2 billion in Q4 2023 and troughed at $22.5 billion in Q4 2022.
  • The 5-year median for Total Liabilities is $117.4 billion (2025), against an average of $111.8 billion.
  • Year-over-year, Total Liabilities soared 424.68% in 2023 and then fell 8.97% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $101.3 billion in 2022, then surged by 35.47% to $137.2 billion in 2023, then fell by 8.97% to $124.9 billion in 2024, then decreased by 2.81% to $121.4 billion in 2025, then fell by 3.44% to $117.2 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Total Liabilities are $117.2 billion (Q1 2026), $121.4 billion (Q4 2025), and $115.6 billion (Q3 2025).